95
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

Allogeneic Tumor Vaccine Produced by Electrofusion between Osteosarcoma Cell Line and Dendritic Cells in the Induction of Antitumor Immunity

, , , , , & show all
Pages 535-541 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhe Yu, Pengcheng Ren, Xudong Zhang, Ting Zhang & Bao’an Ma. (2009) Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities. Expert Review of Anticancer Therapy 9:8, pages 1065-1071.
Read now

Articles from other publishers (11)

Zong-Yuan Jiang, Ji-Bin Liu, Xiao-Feng Wang, Yu-Shui Ma & Da Fu. (2022) Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technology in Cancer Research & Treatment 21, pages 153303382211246.
Crossref
Chaohua Mo, Le Xie, Chang Chen, Jie Ma, Yingxin Huang, Yanxing Wu, Yuanyuan Xu, Huizhi Peng, Zengwei Chen & Rongjun Mao. (2021) The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma. Journal of Oncology 2021, pages 1-18.
Crossref
Zenan Wang, Zhan Wang, Binghao Li, Shengdong Wang, Tao Chen & Zhaoming Ye. (2019) Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma. Frontiers in Immunology 10.
Crossref
Christina K Lettieri, Nicole Appel, Nicole Labban, Danielle M Lussier, Joseph N Blattman & Pooja Hingorani. (2016) Progress and opportunities for immune therapeutics in osteosarcoma. Immunotherapy 8:10, pages 1233-1244.
Crossref
Qiu-Liang Liu, Jiao Zhang, Xin Liu & Jing-Yao Gao. (2015) Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway . Cell Proliferation 48:5, pages 573-581.
Crossref
Zhe Yu, Jixian Qian, Jiachang Wu, Jie Gao & Minghua Zhang. (2012) Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats. Medical Oncology 29:5, pages 3440-3448.
Crossref
Corey M. Munger, Ganapati V. Hegde, Dennis D. Weisenburger, Julie M. Vose & Shantaram S. Joshi. (2012) Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma. Cancer Immunology, Immunotherapy 61:10, pages 1819-1832.
Crossref
David Avigan, Jacalyn Rosenblatt & Donald Kufe. (2012) Dendritic/Tumor Fusion Cells as Cancer Vaccines. Seminars in Oncology 39:3, pages 287-295.
Crossref
Shigeo Koido, Sadamu Homma, Akitaka Takahara, Yoshihisa Namiki, Hideo Komita, Eijiro Nagasaki, Masaki Ito, Keisuke Nagatsuma, Kan Uchiyama, Kenichi Satoh, Toshifumi Ohkusa, Jianlin Gong & Hisao Tajiri. (2011) Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines. Journal of Biomedicine and Biotechnology 2011, pages 1-13.
Crossref
Shigeo Koido, Sadamu Homma, Eiichi Hara, Yoshihisa Namiki, Akitaka Takahara, Hideo Komita, Eijiro Nagasaki, Masaki Ito, Toshifumi Ohkusa, Jianlin Gong & Hisao Tajiri. (2010) Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions. Clinical and Developmental Immunology 2010, pages 1-14.
Crossref
Camille Chauvin, Jean-Marie Philippeau, Caroline Hémont, Francois-Xavier Hubert, Yohann Wittrant, Francois Lamoureux, Benjamin Trinité, Dominique Heymann, Françoise Rédini & Régis Josien. (2008) Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats. Cancer Research 68:22, pages 9433-9440.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.